Mind Medicine (MNMD) Misses Q2 EPS by 13c

Mind Medicine (NASDAQ: MNMD) reported Q2 EPS of ($0.50), $0.13 worse than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Mind Medicine (MNMD) click here.

You May Also Be Interested In

• Godaddy Gets Takeover Offer From Gen Digital - FT
• SYNNEX Corp. (SNX) Tops Q3 EPS by $1.04, Beats on Revenue; Offers Q4 Guidance
• Uxin Limited (UXIN) Reports Q3 EPS of $0.00